Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pneumococcal Vaccination in Aging HIV+ Individuals
NCT02558751Phase 1Completed
- Sponsor
- University of Toledo Health Science Campus
- Start
- Jul 2013
- Primary completion
- Jun 2015
- Modality
- Split/Subunit Vaccines
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of Prevnar 13 and 23-valent pneumococcal polysaccharide vaccine in pneumococcal infection, sponsored by University of Toledo Health Science Campus. Started Jul 2013; status: completed.
02
Drugs
Prevnar 1323-valent pneumococcal polysaccharide vaccine
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT02558751.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02558751.